IL17A and ovarian carcinoma: IL-17 treatment possibly induced EMT in ovarian cancer cell lines via the expression of metastasis-associated genes-1 (MTA1) and targeting the IL-17/MTA-1 axis could be used as a treatment for ovarian cancer [38].